Sihuan Pharmaceutical Holdings Group Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0012 USD
−30.23 M USD
265.24 M USD
4.10 B
About Sihuan Pharmaceutical Holdings Group Ltd.
Sector
Industry
CEO
Wei Cheng Guo
Website
Headquarters
Beijing
Founded
2001
IPO date
Oct 28, 2010
Identifiers
3
ISIN BMG8162K1137
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
159892
ChinaAMC Hang Seng Hong Kong-Listed Biotech Index ETF Units AWeight
0.43%
Market value
2.74 M
USD
513780
INVESCO Great Wall CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
0.60%
Market value
917.21 K
USD
520700
Wanjia CSI Hong Kong Connect Innovative Drug Exchange Traded Fund UnitsWeight
0.57%
Market value
410.51 K
USD
520500
Huatai-PB Hang Seng Innovative Medicine Exchange Traded Fund UnitsWeight
0.30%
Market value
284.08 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of SHPHF is 0.1600 USD — it has increased by 1.20% in the past 24 hours. Watch Sihuan Pharmaceutical Holdings Group Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sihuan Pharmaceutical Holdings Group Ltd. stocks are traded under the ticker SHPHF.
We've gathered analysts' opinions on Sihuan Pharmaceutical Holdings Group Ltd. future price: according to them, SHPHF price has a max estimate of 0.20 USD and a min estimate of 0.20 USD. Watch SHPHF chart and read a more detailed Sihuan Pharmaceutical Holdings Group Ltd. stock forecast: see what analysts think of Sihuan Pharmaceutical Holdings Group Ltd. and suggest that you do with its stocks.
SHPHF reached its all-time high on Mar 14, 2014 with the price of 1.2700 USD, and its all-time low was 0.0002 USD and was reached on Mar 16, 2020. View more price dynamics on SHPHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SHPHF stock is 1.19% volatile and has beta coefficient of 1.17. Track Sihuan Pharmaceutical Holdings Group Ltd. stock price on the chart and check out the list of the most volatile stocks — is Sihuan Pharmaceutical Holdings Group Ltd. there?
Today Sihuan Pharmaceutical Holdings Group Ltd. has the market capitalization of 1.91 B, it has increased by 0.12% over the last week.
Yes, you can track Sihuan Pharmaceutical Holdings Group Ltd. financials in yearly and quarterly reports right on TradingView.
Sihuan Pharmaceutical Holdings Group Ltd. is going to release the next earnings report on Mar 31, 2026. Keep track of upcoming events with our Earnings Calendar.
SHPHF net income for the last half-year is 14.04 M USD, while the previous report showed −25.58 M USD of net income which accounts for 154.87% change. Track more Sihuan Pharmaceutical Holdings Group Ltd. financial stats to get the full picture.
As of Feb 14, 2026, the company has 2.67 K employees. See our rating of the largest employees — is Sihuan Pharmaceutical Holdings Group Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sihuan Pharmaceutical Holdings Group Ltd. EBITDA is 2.33 M USD, and current EBITDA margin is −8.48%. See more stats in Sihuan Pharmaceutical Holdings Group Ltd. financial statements.
Like other stocks, SHPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sihuan Pharmaceutical Holdings Group Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sihuan Pharmaceutical Holdings Group Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sihuan Pharmaceutical Holdings Group Ltd. stock shows the neutral signal. See more of Sihuan Pharmaceutical Holdings Group Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
